Compare GLRE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLRE | BVS |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.5M | 482.9M |
| IPO Year | 2007 | 2016 |
| Metric | GLRE | BVS |
|---|---|---|
| Price | $15.60 | $8.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 84.5K | ★ 306.1K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 75.00 | ★ 163.46 |
| EPS | ★ 2.17 | 0.33 |
| Revenue | ★ $729,777,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ $6.91 | $26.06 |
| Revenue Growth | ★ 4.85 | N/A |
| 52 Week Low | $11.57 | $5.81 |
| 52 Week High | $15.12 | $10.13 |
| Indicator | GLRE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 73.24 | 52.81 |
| Support Level | $12.49 | $6.42 |
| Resistance Level | N/A | $9.01 |
| Average True Range (ATR) | 0.35 | 0.39 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 82.21 | 34.81 |
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.